Fate Therapeutics, Inc. - Common Stock (FATE)
1.3000
-0.0700 (-5.11%)
Fate Therapeutics is a biopharmaceutical company focused on developing innovative cellular therapies for cancer and autoimmune diseases
The company's research centers on harnessing the power of induced pluripotent stem cells to create off-the-shelf, personalized treatments that can be administered to patients with various medical conditions. By leveraging its proprietary technology and expertise in stem cell biology, Fate Therapeutics aims to improve patient outcomes through advanced and sustainable therapeutic options, with a particular emphasis on enhancing the immune system's ability to target and combat disease.
Frequently Asked Questions
Is Fate Therapeutics, Inc. - Common Stock publicly traded?
Yes, Fate Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Fate Therapeutics, Inc. - Common Stock trade on?
Fate Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fate Therapeutics, Inc. - Common Stock?
The ticker symbol for Fate Therapeutics, Inc. - Common Stock is FATE on the Nasdaq Stock Market
What is the current price of Fate Therapeutics, Inc. - Common Stock?
The current price of Fate Therapeutics, Inc. - Common Stock is 1.300
When was Fate Therapeutics, Inc. - Common Stock last traded?
The last trade of Fate Therapeutics, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Fate Therapeutics, Inc. - Common Stock?
The market capitalization of Fate Therapeutics, Inc. - Common Stock is 127.90M
How many shares of Fate Therapeutics, Inc. - Common Stock are outstanding?
Fate Therapeutics, Inc. - Common Stock has 98.38M shares outstanding.